Innoviva is focused on increasing value by maximizing the potential of our respiratory assets partnered with GSK, optimizing our operations and enhancing capital allocation. We continue to diversify our primary royalty management business through actively pursuing acquisitions of promising companies and assets in the healthcare industry where there is significant unmet medical need, often in undervalued therapeutic areas, such as infectious diseases.
Strong, diversified and durable cashflows coupled with deep expertise…
…Enabling long-term thinking and resource deployment…
…In order to drive impact and create value
© 2024 Innoviva. All rights reserved. Terms & Conditions | Privacy Policy | Contact
Sitemap | Terms & Conditions | Privacy Policy | Contact
© 2022 Innoviva. All rights reserved.